EPZ-005687 | m-entrepreneurship.com

Product Name :
EPZ-005687

Search keywords :
EPZ005687

drugId :
null

Target Vo:
Histone-lysine N-methyltransferase EZH2

Target Vo Short Name :
EZH2

Moa_Name:
Histone-lysine N-methyltransferase EZH2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Epizyme Inc

Active Company_Name :
Epizyme Inc

Active Indication_Name:
Lymphoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRCA1 Rabbit pAb Cancer
PDGFR alpha Rabbit mAb Description
SP7/Osterix Antibody: SP7/Osterix Antibody is an unconjugated, approximately 45 kDa, rabbit-derived, anti-SP7/Osterix polyclonal antibody. SP7/Osterix Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit background without labeling.

Author: Betaine hydrochloride

Related Posts